A Novel Biomarker Approach to Exploit HDL for Risk Assessment
J Am Coll Cardiol
.
2019 May 7;73(17):2146-2149.
doi: 10.1016/j.jacc.2019.02.040.
Author
Arnold von Eckardstein
1
Affiliation
1
Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland. Electronic address: arnold.voneckardstein@usz.ch.
PMID:
31047002
DOI:
10.1016/j.jacc.2019.02.040
No abstract available
Keywords:
HDL; biomarker; coronary artery disease; prevention; proteomics.
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Coronary Artery Disease*
Humans
Risk Assessment
Substances
Biomarkers